|
Originally published In Press as doi:10.1074/jbc.M105062200 on July 16, 2001
J. Biol. Chem., Vol. 276, Issue 44, 40502-40509, November 2, 2001
Free Fatty Acids Activate a Vigorous
Ca2+:2H+ Antiport Activity in Yeast
Mitochondria*
Patrick C.
Bradshaw,
Dennis W.
Jung, and
Douglas R.
Pfeiffer
From the Department of Molecular and Cellular Biochemistry,
Ohio State University Medical Center, Columbus, Ohio 43210
Received for publication, June 1, 2001, and in revised form, July 12, 2001
 |
ABSTRACT |
The accumulation and retention of
Ca2+ by yeast mitochondria (Saccharomyces
cerevisiae) mediated by ionophore ETH 129 occurs with a
variable efficiency in different preparations. Ineffective Ca2+ transport and a depressed membrane potential occur in
parallel, are exacerbated in parallel by exogenous free fatty acids,
and are corrected in parallel by the addition of bovine serum
albumin. Bovine serum albumin is not required to develop a high
membrane potential when either Ca2+ or ETH 129 are absent,
and when both are present membrane potential is restored by the
addition of EGTA in a concentration-dependant manner. Respiration and
swelling data indicate that the permeability transition pore does not
open in yeast mitochondria that are treated with Ca2+ and
ETH 129, whereas fatty acid concentration studies and the inaction of
carboxyatractyloside indicate that fatty acid-derived uncoupling does
not underlie the other observations. It is concluded that yeast
mitochondria contain a previously unrecognized
Ca2+:2H+ antiporter that is highly active in
the presence of free fatty acids and leads to a futile cycle of
Ca2+ accumulation and release when exogenous
Ca2+ and ETH 129 are available. It is also shown that
isolated yeast mitochondria degrade their phospholipids at a relatively
rapid rate. The activity responsible is also previously unrecognized. It is Ca2+-independent, little affected by the presence or
absence of a respiratory substrate, and leads to the hydrolysis of
ester linkages at both the sn-1 and sn-2
positions of the glycerophospholipids. The products of this activity,
through their actions on the antiporter, explain the variable behavior
of yeast mitochondria treated with Ca2+ plus ETH 129.
 |
INTRODUCTION |
Ca2+ plays important roles in the cell signaling
systems of eucaryotic organisms (1). In mammalian cells, mitochondria
participate in these systems through the Ca2+ uptake and
release activities that they contain (2). These include a
Ca2+ uniporter for accumulation, an
Na+/Ca2+ exchange activity for release, a
second release activity that is poorly characterized, and a general
diffusion pore that is referred to as the permeability transition pore
(3). Physiological roles of the latter structure are not known with
certainty but are thought to include the propagation of cytoplasmic
Ca2+ waves through repetitive opening and closing of a low
conductance state (4, 5). In addition to influencing extramitochondrial Ca2+-regulated processes, mitochondrial transport
activities adjust the free Ca2+ concentration in the matrix
space and thereby regulate the production of reducing equivalents and
the synthesis of ATP (6).
In simpler eucaryotes such as yeast, the cell signaling roles of
Ca2+ are less developed, and there is a corresponding
reduction in the role of mitochondria in maintaining Ca2+
homeostasis. Yeast mitochondria do not contain a calcium uniporter (7-9) and are thought to lack high activity release carriers that
oppose the uniporter in other mitochondria (10). They do contain a
general diffusion pore in the inner membrane and are subject to a
permeability transition; however, Ca2+ does not regulate
the transition as it does in mammalian mitochondria (8). In addition,
the production of reducing equivalents and ATP synthesis are not
regulated by Ca2+ in yeast mitochondria, in so far as is
known (11). On the other hand, matrix space pyrophosphatase activity is
Ca2+-regulated in mitochondria from both yeast (12) and
mammalian (13) sources, and there may be other roles for
Ca2+ that are unidentified at present.
A study that employed yeast mitochondria loaded with a Ca2+
indicator (fluo-3) showed that the matrix space Ca2+
concentration is established by a simple equilibration with the extramitochondrial concentration (14). The activity responsible appeared to be slow, and it was not clear whether the range of adjustment would encompass that which is attained in yeast cytoplasm through normal processes. In a related study we utilized a strain of
yeast that expresses aequorin in the mitochondria to further investigate the mechanism of equilibration. The presence of a slow
Ca2+ transport activity was confirmed, it was found to be
reversible, and it was seen that a relatively broad range of matrix
space Ca2+ concentrations can be attained via the activity,
similar to the physiological range of variation in
cytoplasm.1 Our study also
showed that yeast mitochondria in vivo accumulate and
retain Ca2+ through the action of ionophore ETH 129, whereas accumulation was transient in the case of isolated
mitochondria. The latter observation conflicted with another report in
which it was seen that isolated yeast mitochondria retain
Ca2+ accumulated via the ionophore under a particular set
of conditions (8).
In the present report we describe further factors that influence
interactions between Ca2+ and yeast mitochondria,
particularly as they relate to Ca2+ transport. The results
show that mitochondria from the yeast Saccharomyces
cerevisiae contain a vigorous Ca2+ transport activity
that has long eluded detection. The activity is regulated by free fatty
acids that arise by degradation of mitochondrial phospholipids, and the
phospholipase responsible for that process is also newly discovered.
Aspects of the data have been described in abstract form (15).
 |
EXPERIMENTAL PROCEDURES |
Preparation of Yeast Mitochondria--
The yeast strain W303-1A
(S. cerevisiae) was grown aerobically at 30 °C in
a medium containing 2% lactate, 1% yeast extract, 2% peptone, 0.05%
dextrose, and 0.01% adenine at pH 5.0, and cells were harvested during
the logarithmic phase (A600 = 1.8-2.2). Mitochondria were isolated from spheroplasts as described previously (8), except that 0.6 M sucrose was used in the
homogenization medium instead of the 0.6 M mannitol that is
usually employed (16). The resulting preparations were maintained on
ice and were suspended in 0.6 M mannitol, 20 mM
HEPES (K+) (pH 6.8), containing 0.75 mg/ml
BSA2 and 0.1 mM
EGTA. Protein concentration was determined by a reduced volume Biuret
method in which 50 µl of the final preparation were solubilized by
adding an equal volume of 10% deoxycholate (Na+), with 0.4 ml of Biuret reagent added to the resulting mixture. BSA was employed
as the standard.
Determination of Ion Transport,  , and Related
Parameters--
Unless noted otherwise, mitochondria were incubated at
1 mg protein/ml and at ~25 °C in a medium that contained 0.6 M mannitol, 10 mM Pi
(K+), 10 mM HEPES (TEA+), pH 7.2, plus 1 mM ethanol as an oxidizable substrate. Compounds having a low solubility in water were added from stock solutions prepared in methanol or Me2SO. Ca2+
transport and membrane potential were monitored using the indicating dyes antipyrylazo III ( A720-790) and safranin O
( A511-533), respectively (17, 18). An SLM Aminco
DW-2C spectrophotometer operated in the dual wavelength mode was
employed for these purposes. The same instrument, operated in split
beam mode, was used to monitor swelling as a decrease in apparent
absorbance of mitochondrial suspensions at 540 nm. Oxygen consumption
data were obtained using a Clark-type electrode in parallel experiments.
Atomic absorption spectroscopy was utilized to monitor the transport of
other cations by yeast mitochondria. Briefly, samples were taken at
appropriate times, and the mitochondria were sedimented rapidly in a
microcentrifuge. After carefully removing supernatants, the pellets
were solubilized with 2 N percholoric acid (overnight) and centrifuged
a second time. The resulting supernatants were diluted with an
appropriate volume of distilled water, and the concentration of the
cation in question was subsequently determined.
Determination of Free Fatty Acids and Mitochondrial
Phospholipids--
Samples containing 3 mg of mitochondrial protein
were extracted by a modified Folch technique (19), following the
addition of a known amount of heptadecanoic acid (17:0), which was
employed as an internal standard (20). The lipid-containing phase was reacted with diazomethane to produce fatty acid methyl esters (21), and
silica gel minicolumns were used to separate these from other fractions
(19). The fatty acid methyl esters were quantitated by gas-liquid
chromatography, using an instrument equipped with a capillary column
and a computing integrator (19, 20). Peak areas were converted to units
of nmol/mg of mitochondrial protein by considering the internal
standard peak area and the amount of protein represented by the sample
(19, 20). Total mitochondrial phospholipids were estimated from
measurements of lipid phosphorous in an aliquot of the initial extract
(22).
 |
RESULTS |
Maintenance of ETH 129-mediated Ca2+ Transport and
 Requires the Presence of BSA--
ETH 129 is an electrogenic
ionophore for divalent cations (23-26) that allows yeast mitochondria
to accumulate Ca2+ in vivo and in
vitro (8).1 Under in vitro
conditions an oxidizable substrate must be present, together with
inorganic phosphate, which is normally used in the concentration range
of 5-10 mM. As in mammalian mitochondria, the substrate is
required to support development of  , which is the immediate
driving force for Ca2+ accumulation. Phosphate is required
to maintain the yeast permeability transition pore (yPTP) in a closed
state, to reduce the transmembrane pH gradient and thereby to enhance
 and, presumably, to reduce the free concentration of
Ca2+ in the matrix space by participating in the formation
of insoluble complexes (8).
While investigating the above features we noticed that ETH 129-mediated
Ca2+ accumulation by yeast mitochondria is subject to
variation in terms of the rate of transport, the external
Ca2+ concentration that is attained, and the tendency of
previously accumulated Ca2+ to be released during an
extended incubation (Fig. 1). This is despite the fact that ETH 129 is a well behaved ionophore for Ca2+ in model systems, displaying properties that are
highly reproducible (26), and despite the fact that the
Ca2+ transport activities of mammalian mitochondria do not
show this degree of variability as long as the permeability transition
is avoided. Accordingly, it appeared that variability reflects specific properties of yeast mitochondrial preparations and that it might relate
to the differing capacity of these mitochondria to retain Ca2+ in vivo and in vitro, as
described in the Introduction.

View larger version (8K):
[in this window]
[in a new window]
|
Fig. 1.
Variable efficiency of ETH 129-mediated
Ca2+ transport in yeast mitochondria. Conditions for
all traces were the same except that different preparations of
mitochondria were employed. The mitochondria were incubated at 1.0 mg
of protein per ml and at 25 °C in a medium that contained 0.6 M mannitol, 10 mM HEPES (TEA+, pH
7.2), 10 mM Pi (K+), 0.5 mM ethanol, 0.5 mg/ml BSA, 0.1 mM antipyrylazo,
and 80 µM CaCl2. Were indicated, 2.4 µM ETH 129 was added to initiate Ca2+
accumulation, which was monitored via the antipyrylazo III signal as
described under "Experimental Procedures." A downward
deflection indicates accumulation, and the heavy bar
associated with each trace shows the signal at an external
Ca2+ concentration of ~0.
|
|
Insight into the underlying cause of variability is provided by Fig.
2, wherein it is shown that
Ca2+ accumulation by freshly prepared yeast mitochondria is
slow and limited in a medium that does not contain BSA. The addition of BSA after transport has begun improves both the rate and extent parameters in a concentration-dependent manner. For the
particular preparation employed when obtaining that figure, a maximal
effect was seen at a BSA concentration near 0.25 mg/ml (~4
µM). BSA is similarly effective when present from the
beginning of incubations, whereas high molecular mass polymers
(10 kDa polyethylene glycol, 100 kDa dextran) that have similar effects
on medium colloid osmotic properties are ineffective (data not
shown).

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 2.
BSA stimulates ETH 129-mediated
Ca2+ transport.
Mitochondria were incubated at 1.0 mg of protein per ml and at
25 °C. The medium contained 0.6 M mannitol, 10 mM HEPES (TEA+, pH 7.2), 10 mM
Pi (K+), 0.1 mM antipyrylazo III,
12 µM safranine O, and 10 µM EGTA
(TEA+). Additions of 1 mM ethanol, 60 µM CaCl2, and 3.6 µM ETH 129 were made as indicated in the figure, and Ca2+ accumulation
was monitored via the antipyrylazo III signal as described under
"Experimental Procedures." A downward deflection
indicates accumulation. When utilized, BSA was added at 0.0625, 0.125, or 0.25 mg/ml, as indicated by the number associated with
the individual traces.
|
|
Effects of BSA on  are examined in Fig.
3. These mitochondria develop and
maintain a large  during ethanol oxidation when BSA is absent,
although BSA increases the magnitude to some degree (Fig.
3A). The addition of Ca2+ or ETH 129 alone has
little effect on  (Fig. 3B); however, both agents
together produce a sustained reduction (Fig. 3C). This
reduction persists for more time than would be required to complete
Ca2+ uptake if BSA were present, based on Fig. 2, and is
not duplicated when ionomycin is added with Ca2+ instead of
ETH 129 (Fig. 3C). Ionomycin is an electroneutral ionophore
for Ca2+ (27, 28) that equilibrates Ca2+ and
H+ gradients across membranes. Accordingly, Fig.
3C shows that the simple presence of Ca2+ in the
mitochondrial matrix space does not effect  . Rather it is the
entry of Ca2+ via an electrogenic process that is
required.

View larger version (9K):
[in this window]
[in a new window]
|
Fig. 3.
Effects of ETH 129 and Ca2+
on  . Mitochondria were
incubated as described in the legend to Fig. 2, except that
antipyrylazo III was not present. For all traces, 1 mM
ethanol was added where indicated, and  was monitored via the
safranine signal as described under "Experimental Procedures." An
upward deflection indicates increasing  . For all
traces, 4 µM of the uncoupler FCCP was added at ~700 s
to determine the signal at  = 0. A, 0.5 mg/ml of
BSA was present or absent from the beginning of the incubation, as
indicated. B, BSA was absent for both traces, and 80 µM CaCl2 or 3.6 µM ETH 129 was
added as indicated. C, same as B except both
CaCl2 and an ionophore were added. The ionophore employed
was ETH 129 or ionomycin, as indicated.
|
|
The sustained reduction of  produced by ETH 129 plus
Ca2+ can be reversed by the subsequent addition of BSA
(Fig. 4). As in the case of enhanced
Ca2+ accumulation (Fig. 2), the degree of reversal is a
function of the BSA concentration such that a direct correlation is
seen between the actions of BSA on  and Ca2+
transport. When BSA is absent and transport is minimal,  is low.
Conversely, the efficient transport seen in the presence of BSA is
associated with a large  .

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 4.
BSA restores
 when Ca2+ and ETH 129 are present. Conditions were the same as described for Fig.
3C, with ETH 129 utilized instead of ionomycin.  was
monitored via the safranine signal as described under "Experimental
Procedures," with an upward deflection of the individual
traces indicating an increasing value. When utilized, BSA was added at
0.0625, 0.125, 0.25, 0.50, or 1.0 mg/ml, as indicated by the
number associated with the individual
traces.
|
|
Additional data pertaining to the sustained reduction of  are
shown in Fig. 5. This reduction is
apparently unrelated to the yeast mitochondrial permeability transition
given that the large amplitude of swelling that accompanies the
transition induced by respiration in the absence of phosphate (compare
Fig. 5, A and B) is not seen when  is
depressed by ETH 129 plus Ca2+ (Fig. 5C).
Furthermore, there is little effect of BSA on respiration when ETH 129 and Ca2+ are present (compare Fig. 5, C and
D), and in neither case does respiration become inhibited as
it does when the transition occurs (compare Fig. 5, A and
B). Other features of the respiration data are also of
interest and are considered under "Discussion."

View larger version (8K):
[in this window]
[in a new window]
|
Fig. 5.
Effects of ETH 129 and Ca2+ on
swelling and respiration. A, mitochondria were incubated at
1.0 mg of protein per ml and at 25 °C. The medium contained 0.6 M mannitol, 10 mM HEPES (TEA+, pH
7.2), 10 mM Pi (K+), and 10 µM EGTA (TEA+). 1 mM ethanol
(ETOH) was added where indicated while swelling
(solid line) and oxygen consumption (dotted line)
were monitored as described under "Experimental Procedures."
B, same as A except the medium did not contain
Pi. C, same as A except that 80 µM CaCl2 and 3.6 µM ETH 129 were added where shown. D, same as C except that
the medium contained BSA at 0.5 mg/ml. As a point of reference, the
rate of oxygen consumption in A was 34.8 ng atoms O/min/mg
protein.
|
|
Analogous Actions of Free Fatty Acids and EGTA--
BSA binds
fatty acids with high affinity but also binds a range of molecules that
are hydrophobic in nature (29, 30). To determine whether the fatty acid
binding activity of BSA is involved in its effects on ETH 129-mediated
Ca2+ transport we first investigated the actions of
exogenous oleate (18:1) on the process. With BSA present initially at
0.5 mg/ml, the addition of increasing oleate levels during
Ca2+ accumulation first inhibited further accumulation and
then caused a reversal of the transport that had already occurred (Fig.
6). These findings indicate that free
fatty acids do indeed diminish Ca2+ transport and that BSA
acts by reducing the available fraction.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 6.
Effect of exogenous oleate on ETH
129-mediated Ca2+ transport. Mitochondria were
incubated, and Ca2+ transport was monitored as described in
the legend to Fig. 2, with 1 mM ethanol and 0.5 mg/ml BSA
present at 0 s. 80 µM CaCl2 and 3.6 µM ETH 129 were added where indicated, followed by an
addition of oleate (Na+) dissolved in methanol. The
number associated with the individual traces
gives the amount added in units of nmol/mg protein.
|
|
Because fatty acids uncouple yeast mitochondria through a mechanism
that requires participation of the adenine nucleotide translocase (31)
it also seemed possible that the Ca2+-releasing activity
of fatty acids and opposing effects of BSA might merely reflect
uncoupling by that type of mechanism. However, we found no effect of
carboxyatractyloside on the depression of  produced by ETH 129 plus Ca2+ when BSA was absent (data not shown). As further
considered under "Discussion," this argues against a significant
role for fatty acid-derived uncoupling, because carboxyatractyloside is
an effective inhibitor of the translocase activity in yeast
mitochondria (32). Furthermore, the depression of  is reversed
when EGTA is added to the external medium. This is seen regardless of
whether Ca2+ transport is occurring early or late during
incubation (compare Fig. 7, A
and B) and whether  has been suppressed briefly or for
an extended period before EGTA is added (compare Fig. 7, A and C). In addition, there is a graded response to multiple
additions of EGTA when the concentration arising from a single addition is less than the total concentration of Ca2+ (Fig.
7C). Thus, a continuing presence of free Ca2+ is
required to maintain the suppression of  even when BSA is not
present to bind fatty acids, and the extent of suppression is a
function of the free Ca2+ concentration.

View larger version (11K):
[in this window]
[in a new window]
|
Fig. 7.
EGTA restores
 when Ca2+ and ETH 129 are present. Mitochondria were incubated, and  was monitored
as described in the legend to Fig. 3. For all panels and
traces, additions of ethanol (ETOH; 1 mM) and CaCl2 (80 µM) and ETH 129 (3.6 µM) were as shown in the figure. 4 µM
of the uncoupler FCCP was added at ~900 s in all cases to determine
the signal at  = 0. A, trace a, the
medium contained 0.5 mg/ml of BSA from 0 s. Trace b,
BSA was not present, and 2 mM EGTA (TEA+) was
added where indicated. B, same as A except the
addition times were altered as shown, to demonstrate that results do
not depend on that variable. C, trace a, same as
A, trace b, except that EGTA was added
incrementally as shown. The first four additions were of 30 µM EGTA, whereas the final addition was 2 mM.
Trace b, same as A, trace b except
that addition of 2 mM EGTA was delayed as shown, again to
demonstrate that results do not depend on the time of addition.
|
|
A further point relating to fatty acid-dependant uncoupling is derived
from Fig. 8. There it is seen that
suppression of  begins immediately during titration with
exogenous oleate when ETH 129, free Ca2+, and BSA are
available (Fig. 8, dotted lines). This is in contrast to the
titration preformed in the presence of excess EGTA where free
Ca2+ is not available, but fatty acid-dependant uncoupling
could still occur. Under those conditions exogenous oleate does not
depress  until the level added exceeds 15 nmol/mg protein. This
shows that the levels of fatty acids required to produce an extensive uncoupling are higher than those that mediate the decrease in 
that arises in the presence of free Ca2+ and ETH 129.

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 8.
Oleate differentially effects
 in the presence and absence of
EGTA. Mitochondria were incubated, and  was monitored as
described in the legend to Fig. 3, except that CaCl2, ETH
129, and BSA were present from the beginning of the incubations. For
the data shown as solid lines, 2 mM EGTA
(TEA+) was also present from the beginning, whereas EGTA
was not present for the data shown as dotted lines. 1 mM ethanol was added at 0 s, followed by repetitive
additions of 5 nmol/mg protein of oleate (Na+) as shown.
When utilized FCCP was added at 4 µM.
|
|
Free Fatty Acids Accumulate in Isolated Yeast
Mitochondria--
To determine whether the free fatty acid levels
in our yeast mitochondria are sufficient to alter Ca2+
transport, these values were determined as a function of incubation time. Indeed, large amounts of free fatty acids accumulate during incubation at 25 °C, at an initial rate of approximately of ~0.4 nmol/min/mg protein (Fig. 9). This rate
was not altered substantially by the presence or absence of ethanol
(Fig. 9, inset), by free Ca2+ and ETH 129, or by
the presence of BSA. However, the rate is decreased to ~0.3
nmol/hr/mg protein when the mitochondria are maintained on ice (data
not shown).

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 9.
Phospholipase activity in isolated yeast
mitochondria. Mitochondria were incubated in 0.6 M
mannitol, 10 mM HEPES (TEA+, pH 7.2), 10 mM Pi (K+), 100 µM
EGTA (TEA+), and 1 mM ethanol. Samples were
taken periodically for the determination of free fatty acids as
described under "Experimental Procedures." The associated
table shows the composition of free fatty acids that were
present in the sample taken at 170 min. Inset, same as the
main panel except that ethanol was present ( ) or absent ( ), and a
shortened time course was employed to conform to the other figures.
FFA, free fatty acids.
|
|
16:0, 16:1, 18:0, and 18:1 account for ~90% of the accumulating
fatty acids (Fig. 9). These compounds and their relative proportions are typical of the fatty acid composition found in yeast phospholipids (33). Parallel determinations of lipid phosphorus showed that the
phospholipid content of the preparations decreased at ~50% of the
rate at which the fatty acids accumulate in total (data not shown).
Furthermore, there was little change in the rate or composition
parameters when Percoll gradient-purified mitochondria (34) were
employed instead of the standard preparation (data not shown).
Accordingly, it appears that the free fatty acids that accumulate arise
from mitochondrial phospholipids and that both sn-1 and sn-2
positions are hydrolyzed by the degradative activities.
 |
DISCUSSION |
Yeast Mitochondria Contain an Endogenous Ca2+ Transport
Activity--
Mammalian mitochondria that are treated with
Ca2+ plus A23187 or ionomycin behave in much the same way
as yeast mitochondria that are treated with Ca2+ plus ETH
129. A23178 and ionomycin are electroneutral ionophores that exchange
matrix space Ca2+ for two external protons. Accordingly
they reverse uniporter-dependent Ca2+
accumulation and a futile cycle of accumulation, and release is
established when the ionophore and the uniporter are active simultaneously (35). This cycle dissipates the proton motive force
(suppresses  ), inhibits Ca2+ accumulation, and
releases Ca2+ that was accumulated previously, depending on
the levels of Ca2+ and the ionophore employed (36, 37).
Given the similarities to those findings, we interpret the present data
to indicate that such a cycle is operating in yeast mitochondria that
are treated with Ca2+ plus ETH 129.
As noted, with yeast mitochondria the cycle arises upon addition of an
electrogenic ionophore whereas an electroneutral ionophore must be
employed with mammalian mitochondria. Given that both an electrogenic
and an electroneutral transporter are required to produce the cycle,
the most straightforward explanation for the difference is that yeast
mitochondria contain a high activity Ca2+ transport
mechanism that is electroneutral, in contrast to mammalian mitochondria
where the dominate mechanism is electrogenic (the Ca2+
uniporter). We adopt this interpretation and propose further that the
yeast activity is regulated by free fatty acids, such that it is poorly
active when free fatty acids are not available (e.g. in the presence of excess BSA), and
progressively more active as the free fatty acid levels rise. These
interpretations explain (i) why efficient Ca2+ accumulation
and retention requires the presence of BSA (to limit activity of the
endogenous transporter that opposes accumulation), (ii) why 
remains suppressed in the presence of ETH 129 plus Ca2+
when BSA is absent (because the ongoing futile cycle continuously expends the proton motive force), and (iii) why  is restored by
the addition of BSA or EGTA (both agents interrupt the cycle).
Potential Alternative Interpretations--
In considering the
merits of the above interpretation it is worthwhile to evaluate other
possibilities. For example, it might be maintained that the free fatty
acids are acting as Ca2+ ionophores, to affect a direct
Ca2+:2H+ exchange, given reports that this
occurs in model systems (e.g. see Refs. 38 and
39), and that fatty acids facilitate monovalent cation transport in
mitochondria (40). We do not favor this interpretation, because the
ionophoretic activities of fatty acids are modest when they have not
been partially oxidized (e.g. see Ref. 41), which
is not the case in the present experiments. In addition, we were unable
to establish an energy-dissipating cycle of Ca2+ uptake and
release by adding exogenous fatty acids to liver mitochondria and then
loading them with Ca2+. At the fatty acid levels of
interest in this study (0-20 nmol/mg protein) an uncoupling effect of
the fatty acid was observed, but this was eliminated substantially upon
Ca2+ accumulation (data not shown). Were the fatty acids
promoting a significant Ca2+:2H+ exchange, an
apparent uncoupling effect would have remained.
It might also be maintained that the yPTP is involved in the actions of
ETH 129 plus Ca2+, because data like those shown in Fig. 1
can be obtained with mammalian mitochondria that are approaching the
permeability transition. In further similarity to the data presented,
the permeability transition in mammalian mitochondria is stimulated by
Ca2+ accumulation, membrane depolarization, and low levels
of free fatty acids, whereas it is reversed by Ca2+
chelation and other maneuvers that counteract inducing conditions (3,
42-44). We do not favor this interpretation, because the present data
were obtained in the presence of 10 mM Pi,
which is fully effective as an inhibitor of the yPTP (8, 45). In addition, decavanadate has no effect on the apparent energy dissipating cycle of Ca2+ accumulation and release (data not shown),
and minimal swelling is seen while the cycle is operating (Fig. 5). The
lack of inhibition by decavanadate is significant, because this
compound is another inhibitor of yPTP and is effective at low
concentrations (46).3 The
absence of swelling means that mannitol (molecular weight = 182) cannot permeate the inner membrane, whereas larger molecules are
permeable when the yPTP is open
(8).4
The respiration data shown in Fig. 5 are also pertinent to a possible
involvement of yPTP. Yeast mitochondria oxidize ethanol at a rate that
is controlled primarily by the kinetic properties of ethanol
dehydrogenase, rather than by limitations reflecting proton pumping
against the electrochemical proton gradient (47-49). Accordingly,
there is usually only a modest effect on the rate of respiration when
yeast mitochondria are uncoupled, provided with the substrates for ATP
synthesis, etc. This can explain why there is little effect of ETH
129-mediated Ca2+ pumping on the rate on respiration, as
seen in Fig. 5. More to the point, when the yPTP is opened respiration
falls dramatically, because matrix space NAD+/NADH is
released from the matrix.3 Because respiration is not
impeded in the presence of Ca2+ and ETH 129, by this
criterion also there is no indication that the yPTP has opened.
The possible involvement of yPTP substates and the recently identified
"nonclassic permeability transition" (50, 51) should also be
considered. yPTP substate involvement seems improbable, because
endogenous Mg2+ is retained when ETH 129 and
Ca2+ are present (see below) and because  is only
fractionally suppressed under those conditions (Fig. 3). Thus, any
pore-like substate that might be involved would have the unlikely
property of accepting Ca2+ while substantially rejecting
Mg2+ and H+. These same factors argue against
an involvement of the nonclassic permeability transition, as does the
absence of swelling. In mammalian mitochondria occurrence of the
nonclassic permeability transition reflects opening of a pore that is
similar in size to the permeability transition pore and requires fatty
acid levels that are substantially higher than those of interest here
(50, 51).
A third type of potential interpretation relates to the uncoupling
activity of fatty acids as described by Skulachev (52) and by others
(53). In that mechanism, protonated free fatty acids rapidly flip-flop
from the outer to the inner monolayer of the inner mitochondrial
membrane and then ionize, delivering a proton to the matrix space.
Thereafter, the uncoupling cycle is completed by transporting
(flipping) the ionized carboxylate function back to the outer
monolayer. The latter step requires catalysis by an anion transporter,
with the adenine nucleotide translocase being primarily responsible in
yeast mitochondria (31). It might be maintained that the efficiency of
this cycle is somehow increased by matrix Ca2+, such that a
given level of free fatty acids would produce more uncoupling following
Ca2+ loading via ETH 129. Although this interpretation can
explain aspects of the present data, it is at odds with the failure of carboxyatractyloside to restore  when Ca2+, ETH 129, and free fatty acids are present (data not shown). It also conflicts
with the inhibitory action of Ca2+ loading on fatty
acid-dependent uncoupling in liver mitochondria, as
mentioned above, and with the failure of ionomycin to substitute for
ETH 129 in promoting the dissipation of  (Fig. 3).
We note further that oleate does not form a tertiary complex with
Ca2+ and ETH 129 that is competent to transport
Ca2+ by an electroneutral mechanism, as shown in a recent
investigation (26). This point is of interest, because such a complex
could, in effect, facilitate the flip-flop of the ionized compound and improve the efficiency of fatty acid-derived uncoupling. With that
possibility also eliminated, there is little prospect for alternative
interpretations wherein the present results would reflect a changing
efficiency of fatty acid-derived uncoupling.
Nature and Specificity of the Transporter--
With alternative
interpretations discounted, it is of interest to consider the reaction
catalyzed by the newly discovered transport activity and to examine its
specificity for Ca2+. As noted above, a straightforward
exchange of Ca2+ for 2H+ is sufficient to
explain the present data, and in fact, the yeast vacuolar membrane is
known to contain a Ca2+ antiporter of this type (54, 55). A
preliminary examination of the yeast proteome data base (56) showed
that additional proteins possessing this activity may be produced by
yeast, and so there are candidates for a mitochondrial isoform.
Nevertheless, it is necessary to consider a possible exchange of
Ca2+ for K+, or for TEA+, because
both were present in the external media at significant concentrations when most of the data were obtained. To do this we
replaced either monovalent cation with the other and observed the
effect on the rate of Ca2+ cycling (suppression of  ).
No effect was seen, which supports the proposed role of H+
(data not shown). We also examined the swelling of yeast mitochondria in media containing high concentrations of Ca2+,
Mg2+, or K+ acetate. Swelling under those
conditions typically reflects entry of the cation in exchange for
H+, accompanied by an uncatalyzed entry of acetic acid
(HA). We found that swelling occurs in Ca2+ or
K+ acetate, but not in Mg2+ acetate, and that
BSA inhibits only in the case of Ca2+ (Fig.
10A). Swelling in
K+ acetate reflects activity of the well known
K+/H+ antiporter in yeast mitochondria (57),
whereas the failure to swell in Mg2+ acetate reflects the
absence of an analogous activity that transports Mg2+ (see
below). The data obtained in Ca2+ acetate are as expected
if yeast mitochondria contain Ca2+:2H+
antiporter that requires free fatty acids for activity, supporting our
interpretation.

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 10.
The Ca2+ release
activity is a H+ antiporter that transports
Sr2+ but not Mg2+. A,
mitochondria were incubated at 1.0 mg of protein per ml and at
25 °C. The medium contained 0.3 M Mg2+,
Ca2+, or K+ acetate, as indicated, 10 mM HEPES (TEA+), pH 7.2, and 4 µM
FCCP. Where indicated, BSA was present at 1.0 mg/ml from 0 s,
which corresponded to the time at which mitochondria were added.
B, mitochondria were incubated as described in the legend to
Fig. 2, with 0.5 mg/ml of BSA and 20 µM oleate present at
0 s. 1 mM ethanol, 80 µM of the
indicated cation chloride, 3.6 µM ETH 129, and 4 µM FCCP were added as shown. At the arrow
labeled sample, a 1-ml aliquot was taken from the 3-ml
volume in the cuvette, and the mitochondria were rapidly sedimented in
a microcentrifuge. The distribution of the exogenous cation between the
supernatant and the pellet was then determined by atomic absorption
spectroscopy, as described under "Experimental Procedures." The
number associated with the individual traces
gives the percent of added cation that was found in the mitochondria.
These samples were also used to determine whether the endogenous
content of Mg2+ had been released. About 85% of the
endogenous Mg2+ was retained in all cases.
|
|
Preliminary data relating to the specificity of the transporter for
Ca2+ are shown in Fig. 10B. In the presence of
ETH 129, BSA, and an excess of oleate, Sr2+ and
Ca2+ are similarly effective at depressing  , but
Mg2+ is ineffective. These data indicate that the
Ca2+ release activity transports Sr2+ if free
fatty acids are available and are in line with the effectiveness of ETH
129 as an ionophore for Sr2+ but not Mg2+ (26).
Also shown are the fractions of the added cations that were found in
the mitochondria during futile cycling. With Ca2+ and
Sr2+ only ~1/3 was internal, consistent with a rapid
release activity that opposes uptake of either cation mediated by the
ionophore. Exogenous Mg2+ remained in the
extramitochondrial volume as expected, but of greater interest,
endogenous Mg2+ was largely retained whereas
Ca2+ or Sr2+ cycling is ongoing (see the legend
to Fig. 10B). The latter observation indicates that the
release activity is selective against Mg2+.
Phospholipid Degradation and Biological Implications--
Despite
the available genomic sequence, little is known about the function and
regulation of phospholipases in yeast (33). Yost et al. (58)
used an assay based on exogenous substrates to show that disrupted
mitochondria from cells grown on a fermentable or nonfermentable carbon
source display phospholipase A1 and A2 activities. To our knowledge, our report is the first description of
endogenous phospholipid degradation within the intact organelle. As in
the earlier study, the activity described here is
Ca2+-independent and substantial. For comparison, the
initial rate is sufficient to degrade about 5% of total mitochondrial
phospholipids within 1 h, which is similar to the activities found
in rat liver and heart mitochondria (43, 59). The activity described
here was observed at pH 7.2, whereas Yost et al. (58) found
high activity at pH 5 and 9 and minimal activity near pH 7. Differences reflecting the form of substrate presentation may explain the variation.
Based on the present data, it is clear that free fatty acids arise in
isolated yeast mitochondria at a rate sufficient to strongly influence
the Ca2+ transporter on a time scale of minutes.
Nevertheless, it is not clear how the phospholipase activity and free
fatty acid levels would be controlled in vivo, so it is
difficult to project a physiological function for the Ca2+
transporter based upon regulation of this type.
The high specific activity and directionality of the transporter are
additional factors to consider. From Figs. 1, 2, and 5, yeast
mitochondria can accumulate Ca2+ at a rate of ~40
nmol/min/mg protein when the ETH 129 level is 2.4 nmol/mg protein. This
is a minimal estimate of activity for the release carrier, because the
accumulation rate can be entirely negated when sufficient free fatty
acids are present (Fig. 5). This rate greatly exceeds the rate of
Ca2+ release from rat liver mitochondria when the
permeability transition is avoided and more modestly exceeds the
maximal release rates that can be attained in heart and brain
mitochondria (3). The true rate available in yeast mitochondria may, of
course, be still higher. The rapid rate of Ca2+ release
suggests that the activity responsible participates in regulating cell
Ca2+ levels in yeast. However, if the activity indeed
exchanges Ca2+ for 2H+, it would seem that the
pH gradient would have to reverse its normal orientation for a net
accumulation of Ca2+ to occur. It remains to be determined
whether this is possible in vivo.
As a final point, it is interesting to note that mitochondria are
thought to have arisen from a symbiotic bacterium and that antiport-type Ca2+ transport activities are common in the
envelope membrane of bacteria, whereas gated Ca2+ channels
are not common (60). Considering yeast to be a primitive eucaryote, the
present data then suggest that the earliest mitochondria were able to
transport Ca2+ by an antiport activity alone. The
Ca2+ uniporter, which is thought to be a gated
Ca2+ channel (3, 61), must have arisen later, at a point in
evolution that remains to be determined.
 |
FOOTNOTES |
*
This work was supported by The Wallace Research
Foundation, by American Heart Association Grant 9650626N, and by a
grant from MitoKor, Inc. (San Diego, CA).The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Molecular and
Cellular Biochemistry, Ohio State University, 1645 Neil Ave., Hamilton
Hall 310A, Columbus, Ohio 43210-1218. Tel.: 614-292-8774; Fax:
614-292-4118; E-mail: pfeiffer.17@osu.edu.
Published, JBC Papers in Press, July 16, 2001, DOI 10.1074/jbc.M105062200
1
Submitted for publication.
3
Manuscript in preparation.
4
The actions of cyclosporin A, a potent inhibitor
of the permeability transition in mammalian mitochondria, are not
considered here, because this compound does not inhibit the yPTP
(8).
 |
ABBREVIATIONS |
The abbreviations used are:
BSA, bovine serum
albumin;
 , membrane potential, FCCP, carbonyl cyanide
p-trifluoromethoxyphenylhydrazone;
TEA+, tetraethylammonium cation;
yPTP, yeast mitochondrial permeability
transition pore.
 |
REFERENCES |
| 1.
|
Pozzan, T.,
Rizzuto, R.,
Volpe, P.,
and Meldolesi, J.
(1994)
Physiol. Rev.
74,
595-636
|
| 2.
| Babcock, D. F., and Hille, B. (1998) Curr. Opin.
Neurobiol. 398-404
|
| 3.
|
Gunter, T. E.,
and Pfeiffer, D. R.
(1990)
Am. J. Physiol.
258,
C755-C786
|
| 4.
|
Ichas, F.,
Jouaville, L. S.,
and Mazat, J.-P.
(1997)
Cell
89,
1145-1153
|
| 5.
|
Jouaville, L. S.,
Ichas, F.,
Holmuhamedov, E. L.,
Camacho, P.,
and Lechleiter, J. D.
(1995)
Nature
377,
438-441
|
| 6.
|
Hansford, R. G.
(1994)
J. Bioenerg. Biomembr.
26,
495-508
|
| 7.
|
Balcavage, W. X.,
Lyoyd, J. L.,
Mattoon, J. R.,
Ohnishi, T.,
and Scarpa, A.
(1973)
Biochim. Biophys. Acta
305,
41-51
|
| 8.
|
Jung, D. W.,
Bradshaw, P. C.,
and Pfeiffer, D. R.
(1997)
J. Biol. Chem.
272,
21104-21112
|
| 9.
|
Manon, S.,
and Guérin, M.
(1993)
J. Bioenerg. Biomembr.
25,
671-678
|
| 10.
|
Weihua, L.,
Shariat-Madar, Z.,
Powers, M.,
Sun, X.,
Lane, R. D.,
and Garlid, K. D.
(1992)
J. Biol. Chem.
267,
17983-17989
|
| 11.
|
Nichols, B. J.,
Rigoulet, M.,
and Denton, R. M.
(1994)
Biochem. J.
303,
461-465
|
| 12.
|
Uribe, S.,
Rangel, P.,
Pardo, J. P.,
and Pereira-da-Silva, L.
(1993)
Eur. J. Biochem.
217,
657-660
|
| 13.
|
Davidson, A. M.,
and Halestrap, A. P.
(1989)
Biochem. J.
258,
817-821
|
| 14.
|
Uribe, S.,
Rangel, P.,
and Pardo, J. P.
(1992)
Cell Calcium
13,
211-217
|
| 15.
|
Bradshaw, P. C.,
Jung, D. W.,
and Pfeiffer, D. R.
(2000)
Biophys. J.
78,
194. A
|
| 16.
|
Daum, G.,
Bohni, P. C.,
and Schatz, G.
(1982)
J. Biol. Chem.
257,
13028-13033
|
| 17.
|
Åkerman, K. E. O.,
and Wikström, M. K. F.
(1976)
FEBS Lett.
68,
191-197
|
| 18.
|
Scarpa, A.,
Brinley, F. J., Jr.,
and Dubyak, G.
(1978)
Biochemistry
17,
1378-1386
|
| 19.
|
Broekemeier, K. M.,
Schmid, P. C.,
Schmid, H. H. O.,
and Pfeiffer, D. R.
(1985)
J. Biol. Chem.
260,
105-113
|
| 20.
|
Pfeiffer, D. R.,
Schmid, P. C.,
Beatrice, M. C.,
and Schmid, H. H. O.
(1979)
J. Biol. Chem.
254,
11485-11494
|
| 21.
|
Schlenk, H.,
and Gellerman, J.
(1960)
Anal. Chem.
32,
1412-1414
|
| 22.
|
Bartlett, G. R.
(1959)
J. Biol. Chem.
234,
466-468
|
| 23.
|
Prestipino, G.,
Falugi, C.,
Falchetto, R.,
and Gazzotti, P.
(1993)
Anal. Biochem.
210,
119-122
|
| 24.
|
Pretsch, E.,
Ammann, D.,
Osswald, H.,
Güggi, M.,
and Simon, W.
(1980)
Helv. Chim. Acta
63,
191-196
|
| 25.
|
Schefer, U.,
Ammann, D.,
Pretsch, E.,
Oesch, U.,
and Simon, W.
(1986)
Anal. Chem.
58,
2282-2285
|
| 26.
| Wang, E., Erdahl, W. L., Hamidinia, S. A., Chapman, C. J., Taylor, R. W., and Pfeiffer, D. R. (2001) Biophys.
J., in press
|
| 27.
|
Erdahl, W. L.,
Chapman, C. J.,
Taylor, R. W.,
and Pfeiffer, D. R.
(1994)
Biophys. J.
66,
1678-1693
|
| 28.
|
Thomas, T. P.,
Wang, E.,
Pfeiffer, D. R.,
and Taylor, R. W.
(1997)
Arch. Biochem. Biophys.
342,
351-361
|
| 29.
|
Elmadhoun, B. M.,
Wang, G. Q.,
Templeton, J. F.,
and Burzczynski, F. J.
(1998)
Am. J. Physiol. Gastrointest. Liver Physiol.
275,
G638-G644
|
| 30.
|
Nissani, E.,
Koren, R.,
and Perlmutter-Hayman, B.
(1983)
Arch. Biochem. Biophys.
226,
357-364
|
| 31.
|
Polcic, P.,
Sabová, L.,
and Kolarov, J.
(1997)
FEBS Lett.
412,
207-210
|
| 32.
|
Brandolin, G.,
Le Saux, A.,
Trezeguet, V.,
Vignais, P. V.,
and Lauquin, G. J. M.
(1993)
Biochem. Biophys. Res. Commun.
192,
143-150
|
| 33.
|
Daum, G.,
Lees, N. D.,
Bard, M.,
and Dickson, R.
(1998)
Yeast
14,
1471-1510
|
| 34.
|
Broekemeier, K. M.,
Schmid, P. C.,
Dempsey, M. E.,
and Pfeiffer, D. R.
(1991)
J. Biol. Chem.
266,
20700-20708
|
| 35.
|
Reed, P. W.,
and Lardy, H. A.
(1972)
J. Biol. Chem.
247,
6970-6977
|
| 36.
|
Kaufman, R. F.,
Taylor, R. W.,
and Pfeiffer, D. R.
(1980)
J. Biol. Chem.
255,
2735-2739
|
| 37.
|
Pfeiffer, D. R.,
Hutson, S. M.,
Kaufman, R. F.,
and Lardy, H. A.
(1976)
Biochemistry
15,
2690-2697
|
| 38.
|
Utsumi, K.,
Nobori, K.,
Terada, S.,
Miyahara, M.,
and Utsumi, T.
(1985)
Cell Struct. Funct.
10,
339-348
|
| 39.
|
Sharpe, M. A.,
Cooper, C. E.,
and Wrigglesworth, J. M.
(1994)
J. Membr. Biol.
141,
21-28
|
| 40.
|
Wojtczak, L.,
and Wieckowski, M. R.
(1999)
J. Bioenerg. Biomembr.
31,
447-455
|
| 41.
|
Serhan, C. N.,
Anderson, P.,
Goodman, E.,
Dunham, P.,
and Weissmann, G.
(1981)
J. Biol. Chem.
256,
2736-2741
|
| 42.
|
Bernardi, P.,
Broekemeier, K. M.,
and Pfeiffer, D. R.
(1994)
J. Bioenerg. Biomembr.
26,
509-517
|
| 43.
|
Broekemeier, K. M.,
and Pfeiffer, D. R.
(1995)
Biochemistry
34,
16440-16449
|
| 44.
|
Broekemeier, K. M.,
Klocek, C. K.,
and Pfeiffer, D. R.
(1998)
Biochemistry
37,
13059-13065
|
| 45.
|
Guerin, B.,
Bunoust, O.,
Rouqueys, V.,
and Rigoulet, M.
(1994)
J. Biol. Chem.
269,
25406-25410
|
| 46.
|
Roucou, X.,
Manon, S.,
and Guérin, M.
(1997)
Biochim. Biophys. Acta
1324,
120-132
|
| 47.
|
Ouhabi, R.,
Rigoulet, M.,
Lavie, J.-L.,
and Guérin, B.
(1991)
Biochim. Biophys. Acta
1060,
293-298
|
| 48.
|
Fitton, V.,
Rigoulet, M.,
Ouhabi, R.,
and Guérin, B.
(1994)
Biochemistry
33,
9692-9698
|
| 49.
|
Avéret, N.,
Fitton, V.,
Bunoust, O.,
Rigoulet, M.,
and Guérin, B.
(1998)
Mol. Cell. Biochem.
184,
67-79
|
| 50.
|
Sultan, A.,
and Sokolove, P. M.
(2001)
Arch. Biochem. Biophys.
386,
52-61
|
| 51.
|
Sultan, A.,
and Sokolove, P. M.
(2001)
Arch. Biochem. Biophys.
386,
37-51
|
| 52.
|
Skulachev, V. P.
(1998)
Biochim. Biophys. Acta
1363,
100-124
|
| 53.
|
Wojtczak, L.,
Wieckowski, M. R.,
and Schönfeld, P.
(1998)
Arch. Biochem. Biophys.
357,
76-84
|
| 54.
|
Dunn, T.,
Gable, K.,
and Beeler, T.
(1994)
J. Biol. Chem.
269,
7273-7278
|
| 55.
|
Cunningham, K. W.,
and Fink, G. R.
(1996)
Mol. Cell. Biol.
123,
2226-2237
|
| 56.
|
Hodges, P. E.,
McKee, A. H. Z.,
Davis, B. P.,
Payne, W. E.,
and Garrels, J. I.
(1999)
Nucleic Acids Res.
27,
69-73
|
| 57.
|
Manon, S.,
and Guérin, M.
(1992)
Biochim. Biophys. Acta
1108,
169-176
|
| 58.
|
Yost, R. W.,
Grauvickel, S. J.,
Cantwell, R.,
Bomalaski, J. S.,
and Hudson, A. P.
(1991)
Biochem. Int.
24,
199-208
|
| 59.
|
Palmer, J. W.,
Schmid, P. C.,
Pfeiffer, D. R.,
and Schmid, H. H. O.
(1981)
Arch. Biochem. Biophys.
211,
674-682
|
| 60.
|
Norris, V.,
Grant, S.,
Freestone, P.,
Canvin, J.,
Sheikh, F. N.,
Toth, I.,
Trinel, M.,
Modha, K.,
and Norman, R. I.
(1996)
J. Bacteriol.
178,
3677-3682
|
| 61.
|
Litsky, M. L.,
and Pfeiffer, D. R.
(1997)
Biochemistry
36,
7071-7078
|
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Eimre, R. Puhke, K. Alev, E. Seppet, A. Sikkut, N. Peet, L. Kadaja, A. Lenzner, T. Haviko, T. Seene, et al.
Altered mitochondrial apparent affinity for ADP and impaired function of mitochondrial creatine kinase in gluteus medius of patients with hip osteoarthritis
Am J Physiol Regulatory Integrative Comp Physiol,
May 1, 2006;
290(5):
R1271 - R1275.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|